Eckert & Ziegler Strahlen- und Medizintechnik AG
EUZ | F
Overview
Corporate Details
- ISIN(s):
- DE0005659700
- LEI:
- 391200EUDABLUKXCKG48
- Country:
- Germany
- Address:
- Robert-Rössle-Str. 10, 13125 Berlin
- Website:
- https://www.ezag.com/startseite/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
The Eckert & Ziegler Group is one of the world's largest providers of isotope technology for medical, scientific and industrial use. The core businesses of the Group are cancer therapy, industrial radiometry and nuclear-medical imaging. The two business segments are: Medical and Isotope Products. Eckert & Ziegler was founded in 1997 as a holding company.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 10:00 |
Regulatory News Service
Eckert & Ziegler: Illuccix PSMA-PET Imaging Agent Receives Approval in Germany
|
English | 7.1 KB | |
| 2025-05-30 10:00 |
Regulatory News Service
Eckert & Ziegler Organizes Third Boston Radionuclide Theranostics Forum
|
English | 8.0 KB | |
| 2025-05-23 10:00 |
Regulatory News Service
Eckert & Ziegler Wins Best Managed Companies Award for the Second Time
|
English | 7.1 KB | |
| 2025-05-13 07:45 |
Regulatory News Service
Eckert & Ziegler Starts with Earnings Growth in Q1 2025 and Confirms Full-Year …
|
English | 7.6 KB | |
| 2025-05-13 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 1.7 MB | |
| 2025-05-07 15:05 |
General Meeting Notice
Eckert & Ziegler SE: Bekanntmachung der Einberufung zur Hauptversammlung am 18.…
|
German | 85.4 KB | |
| 2025-05-02 21:13 |
Regulatory News Service
|
English | 12.3 KB | |
| 2025-04-28 00:00 |
Regulatory News Service
Annual financial report 2024 (PDF)
|
English | 3.6 MB | |
| 2025-04-25 00:00 |
Regulatory News Service
Annual financial report 2024 (PDF)
|
English | 3.6 MB | |
| 2025-04-24 14:00 |
Regulatory News Service
Eckert & Ziegler Signs Contract Manufacturing Agreement for Yttrium-90-based Pe…
|
English | 8.7 KB | |
| 2025-04-12 10:30 |
Regulatory News Service
Eckert & Ziegler Proposes Dividend of 0.50 for FY 2024
|
English | 5.7 KB | |
| 2025-04-11 11:38 |
Directors' Dealings
Eckert & Ziegler SE: Dr. Harald Hasselmann, Allocation of 18,048 shares as part…
|
English | 6.1 KB | |
| 2025-04-10 15:00 |
Regulatory News Service
Eckert & Ziegler: US Consul Visits Radiopharmaceutical Production in Braunschwe…
|
English | 7.1 KB | |
| 2025-03-27 07:45 |
Regulatory News Service
Eckert & Ziegler: Record year 2024 with new all-time highs
|
English | 7.5 KB | |
| 2025-03-25 09:30 |
Regulatory News Service
Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensi…
|
English | 10.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2021-10-05 | Völkerding, Leo | Supervisory board | Sell | None | 20,895.24 EUR |
| 2021-10-05 | Foerster, Christina | Board | Other | None | 2,608.00 EUR |
| 2021-10-04 | Günther, Bernd | Supervisory board | Buy | None | 2,220.00 EUR |
| 2021-10-01 | Hasselmann, Anja | Close relation | Buy | None | 9,954.00 EUR |
| 2021-08-17 | Hasselmann, Dr. Harald | Board | Sell | None | 228,600.00 EUR |
| 2021-08-17 | Perschmann, Frank | Supervisory board | Sell | None | 51,235.00 EUR |
| 2021-08-16 | Schröter, Jasmin | Close relation | Buy | None | 214,969.08 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |